Skip to main content
| News

Bottmedical enters the market with innovative braces

27.07.2021

The Basel-based startup Bottmedical has developed clear aligners made from bio-based polymers. After closing a successful financing round, the company has now entered the market. An increasing number of clinics are now using the innovative braces.

Bottmedical Tino, Marie, Elise, NA
Inspired minds at work (img: Bottmedical)

Bottmedical has developed clear braces made from bio-based polymers, further details of which can be found in an article on startupticker.ch. Founded as a spin-off from the University of Basel and headquartered in Technologiepark Basel, Bottmedical has already supplied its product to customers located across Europe and recently initiated global expansion plans in Japan and Australia. In Switzerland, Naturaligner is available at ever more clinics, while the University of Basel is testing the product’s biomechanical properties in a clinical trial currently in progress.

It was only in April that the Basel-based company closed a financing round by securing gross proceeds in the amount of 1.1 million Swiss francs. At present, a Series B financing round is being prepared for the pending growth phase. The aim here is to ensure that Naturaligner will be available to one million patients at 2024.

“We are pioneers in the field of bio-based polymers for dental medicine. Our aim is to reduce patient exposure to harmful microplastics and plasticizers”, explains Tino Töpper, co-founder and CEO of Bottmedical, in an article with the ‘Basler Zeitung’ newspaper. In the next step, Bottmedical will functionalize the material with antibacterial subsistence to support the prevention of caries foundation.

While Bottmedical is working to expand production capacities, the company is also already focused on the development of its next product. Ultra-thin sensors are designed to function as an interface between the tongue and an app. “The Tofi-Trainer facilitates interactive and entertaining training of the muscle fiber-related tongue motor skills in order to improve the tension and the subconscious control of the tongue at night”, Töpper stated to ‘Basler Zeitung’. In this way, both snoring and sleep apnea could be treated.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 55

Do you have a question? We'd like to hear from you.